Rayaldee

Active Ingredient(s): Calcifediol
FDA Approved: * June 17, 2016
Pharm Company: * OPKO IRELAND GLOBAL HOLDINGS LTD
Category: Osteoporosis

Calcifediol, also known as calcidiol, 25-hydroxycholecalciferol, or 25-hydroxyvitamin D3 (abbreviated 25(OH)D3),[1] is a form of vitamin D produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme vitamin D 25-hydroxylase.[2][3][4] Calcifediol can be further hydroxylated by the enzyme 25(OH)D-1α-hydroxylase, primarily in the kidney, to form calcitriol (1,25-(OH)2D3), which is the active hormonal fo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rayaldee 30 ug/1 Oral Capsule, Extended Release
NDC: 70301-1001
Labeler:
Opko Pharmaceuticals LLC
Rayaldee 30 ug/1 Oral Capsule, Extended Release
NDC: 70301-1002
Labeler:
Opko Pharmaceuticals LLC

Related Brands

Drugs with the same active ingredients